期刊文献+

肾性骨病的治疗进展

原文传递
导出
摘要 目的肾性骨病与现代医学许多研究结果提示,肾与骨的联系是通过肾细胞与骨细胞的“对话”或“通讯”来实现的,在骨代谢中起主要作用的物质钙﹑磷﹑活性维生素D﹑甲状旁腺激素(PTH)等,都与肾脏功能密切相关.药物治疗可使变细的骨小梁增粗,穿孔得以修复,但尚不能使已断裂的骨小梁再连接,也就是不能使已破坏的骨组织微结构完全修复,因此,预防比治疗更为重要和有意义[1].采取积极有效的措施来预防CKD3期肾性骨病的发生较发病后更为关键.以下就肾性骨病的治疗和预防用药详细叙述如下,
出处 《实用心脑肺血管病杂志》 2016年第B04期128-128,共1页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
  • 相关文献

参考文献1

二级参考文献11

  • 1[1]Block GA, Hulbert-Shearon TE, Levin NW, et al. Association of serum phosphorus and calcium × phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis,1998, 31:607-617
  • 2[2]Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis, 2000, 35:1226-1237
  • 3[3]Wingen AM, Fabian-Bach C, Schaefer F, et al. Randomised multicentre study of a low-protein diet on the progression of chronic renal failure in children. European Study Group of Nutritional Treatment of Chronic Renal Failure in Childhood. Lancet, 1997, 349:1117-1123
  • 4[4]Delmez JA, Kelber J, Norword KY, et al. Magnesium carbonate as a phosphorus binder: A prospective, controlled, crossover study. Kidney Int, 1996, 49:163-167
  • 5[5]Chertow GM, Burke SK, Lazarus JM, et al. Poly[allylamine hydrochloride](RenaGel): A noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure]. Am J Kidney Dis,1997, 29:66-71
  • 6[6]Foley RN, Parfrey PS, Harnett JD, et al. Hypocalcemia, morbidity, and mortality in end-stage renal disease. Am J Nephrol, 1996, 16:386-393
  • 7[7]Nordal KP, Dahl E, Halse J, et al. Long-term low-dose calcitriol treatment in predialysis chronic renal failure: Can it prevent hyperparathyroid bone disease? Nephrol Dial Transplant, 1995, 10:203-206
  • 8[8]Herrmann P, Ritz E, Schmidt-Gayk H, et al. Comparison of intermittent and continuous oral administration of calcitriol in dialysis patients: A randomized prospective trial, Nephron,1994, 67(1):48-53
  • 9[9]Liou HH, Chiang SS, Huang TP, et al. Akmal M: Comparative effect of oral or intravenous calcitriol on secondary hyperparathyroidism in chronic hemodialysis patients. Miner Electrolyte Metab, 1994, 20:97-102
  • 10[10]Fabretti F, Calabrese V, Fornasari V, et al. Subtotal parathyroidectomy for secondary hyperparathyroidism in chronic renal failure. J Laryngol Otol,1991, 105:562-567

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部